Search research articles
Contact Us
Filters
Showing results (1-10 of 48) with videos related to
Page
of 5
Sort By:
Current Cardiology Reviews
|
March 2, 2016
Drug-induced Inhibition and Trafficking Disruption of ion Channels: Pathogenesis of QT Abnormalities and Drug-induced Fatal Arrhythmias
Luigi X Cubeddu
Bioimpacts : BI
|
September 22, 2023
Epigenetics of the blood pressure reactivity to salt: Is the salt sensitive phenotype correctable?
Luigi X Cubeddu
American Journal of Therapeutics
|
November 19, 2003
QT prolongation and fatal arrhythmias: a review of clinical implications and effects of drugs
Luigi X Cubeddu
Current Cardiology Reviews
|
August 3, 2010
Iatrogenic QT Abnormalities and Fatal Arrhythmias: Mechanisms and Clinical Significance
Luigi X Cubeddu
Current Atherosclerosis Reports
|
November 25, 2010
Statin rebound or withdrawal syndrome: does it exist?
Andres Pineda, Luigi X Cubeddu
Pharmacotherapy
|
September 2, 2006
Statin withdrawal: clinical implications and molecular mechanisms
Luigi X Cubeddu, Matthew J Seamon
The Journal of Pharmacology and Experimental Therapeutics
|
June 18, 2002
The selective serotonin reuptake inhibitor citalopram induces the storage of serotonin in catecholaminergic terminals
Heberto Suarez-Roca, Luigi X Cubeddu
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
June 17, 2008
Salt and the metabolic syndrome
Irene S Hoffmann, Luigi X Cubeddu
Metabolic Syndrome and Related Disorders
|
October 29, 2011
Metabolic syndrome: an all or none or a continuum load of risk?
Luigi X Cubeddu, Irene S Hoffmann
Metabolic Syndrome and Related Disorders
|
September 22, 2010
One-hour postload plasma glucose levels, a predictor of additional risk for diabetes: prevalence, mechanisms, and associated cardiovascular and metabolic risk factors in Hispanics
Luigi X Cubeddu, Irene S Hoffmann
Page
of 5
Search research articles
Search
Showing results (1-10 of 48) with videos related to
Sort By:
Page
of 5
Current Cardiology Reviews
|
March 2, 2016
Drug-induced Inhibition and Trafficking Disruption of ion Channels: Pathogenesis of QT Abnormalities and Drug-induced Fatal Arrhythmias
Luigi X Cubeddu
Bioimpacts : BI
|
September 22, 2023
Epigenetics of the blood pressure reactivity to salt: Is the salt sensitive phenotype correctable?
Luigi X Cubeddu
American Journal of Therapeutics
|
November 19, 2003
QT prolongation and fatal arrhythmias: a review of clinical implications and effects of drugs
Luigi X Cubeddu
Current Cardiology Reviews
|
August 3, 2010
Iatrogenic QT Abnormalities and Fatal Arrhythmias: Mechanisms and Clinical Significance
Luigi X Cubeddu
Current Atherosclerosis Reports
|
November 25, 2010
Statin rebound or withdrawal syndrome: does it exist?
Andres Pineda, Luigi X Cubeddu
Pharmacotherapy
|
September 2, 2006
Statin withdrawal: clinical implications and molecular mechanisms
Luigi X Cubeddu, Matthew J Seamon
The Journal of Pharmacology and Experimental Therapeutics
|
June 18, 2002
The selective serotonin reuptake inhibitor citalopram induces the storage of serotonin in catecholaminergic terminals
Heberto Suarez-Roca, Luigi X Cubeddu
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
June 17, 2008
Salt and the metabolic syndrome
Irene S Hoffmann, Luigi X Cubeddu
Metabolic Syndrome and Related Disorders
|
October 29, 2011
Metabolic syndrome: an all or none or a continuum load of risk?
Luigi X Cubeddu, Irene S Hoffmann
Metabolic Syndrome and Related Disorders
|
September 22, 2010
One-hour postload plasma glucose levels, a predictor of additional risk for diabetes: prevalence, mechanisms, and associated cardiovascular and metabolic risk factors in Hispanics
Luigi X Cubeddu, Irene S Hoffmann
Page
of 5